Our | Products


Xgeva





THERAPEUTIC AREA: Oncology / Hematology
ACTIVE PRINCIPLE: Denosumab
PRESENTATION: 120 mg /1,7 ml Solution for Injection Vial x 1
INDICATION:

  • Bone metastases from solid tumors
  • Giant cell tumor of bone